Selected Drugs Clear All
MultiCheck Results
- 5
Interactions
Avoid/Use Alternative |
||
|
Primatene Mist
(epinephrine inhaled) + trospium
(generic) |
||
Avoid/Use Alternativeepinephrine inhaled + trospium avoid combo: combo may incr. risk of tachycardia (additive effects) |
||
Monitor/Modify Tx |
||
|
Dilantin
(phenytoin) + magnesium citrate
(generic) |
||
Monitor/Modify Txphenytoin + magnesium citrate consider giving oral phenytoin at least 2h before or 6h after magnesium citrate; monitor phenytoin levels: combo may decr. phenytoin levels, efficacy; may alter seizure control (absorption decreased via chelation; antagonistic effects, magnesium citrate may decr. seizure threshold) |
||
Caution Advised |
||
|
Dilantin
(phenytoin) + Mirvaso
(brimonidine topical) |
||
Caution Advisedphenytoin + brimonidine topical caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
|
Dilantin
(phenytoin) + trospium
(generic) |
||
Caution Advisedphenytoin + trospium caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
|
Mirvaso
(brimonidine topical) + trospium
(generic) |
||
Caution Advisedbrimonidine topical + trospium caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
Additional Considerations |
||
|
trospium
|
||
|
avoid combo with beverages or products containing ethanol within 2h of trospium extended-release (ER) capsules administration; combo may incr. trospium release rate, levels, risk of adverse effects, decr. duration of efficacy |
||
|
magnesium citrate
|
||
|
separate administration from other oral drugs by at least 1h; magnesium citrate may decr. absorption of concomitant oral drugs |
||